跳到主要內容

臺灣博碩士論文加值系統

(216.73.217.114) 您好!臺灣時間:2026/11/16 17:23
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:鄭祿鈞
研究生(外文):Lu-Jun Zheng
論文名稱:利用氧化石墨烯量子點包裹脫氧葡萄糖進行深層放射協同治療
論文名稱(外文):Radiotherapy synergistic therapy of treating deep-seated use 2-deoxy-d-glucose coated graphene quantum dot
指導教授:劉澤英
指導教授(外文):Tse-Ying Liu
學位類別:碩士
校院名稱:國立陽明大學
系所名稱:生物醫學工程學系
學門:工程學門
學類:生醫工程學類
論文種類:學術論文
論文出版年:2018
畢業學年度:106
語文別:中文
論文頁數:71
中文關鍵詞:石墨烯量子點、放射治療、轉移
外文關鍵詞:Graphene Quantum Dot、radiotherapy、metastasis
相關次數:
  • 被引用被引用:0
  • 點閱點閱:394
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
本研究中我們通過使用脫氧葡萄糖(2-Deoxy-d-Glucose)結合石墨烯量子點(Graphene Quantum Dot)(GQD-2DG)的設計作為被動靶向載體遞送系統,實現了高度特異性的協同放射治療。實驗中藉由TEM得知GQD-2DG的size約為35nm,以FTIR來判定GQD有接上2DG以及使用拉曼光譜看接上2DG後並不會改變GQD的光學性質,我們可以在共軛焦(Confocal)的實驗裡看到2DG的接枝有效提高骨肉瘤癌細胞的吞噬,在動物實驗裡使用EPR機制將2DG-GQDs複合物經由血液遞送載體至骨肉瘤細胞使納米載體顯著增加腫瘤細胞中的積聚,並同時用6MV X射線照射進行放射增效,並同時抑制骨肉瘤的遠端轉移。在本研究中可以看到GQD-2DG結合放射治療可以有效降低腫瘤大小並同時抑制骨肉瘤的遠端轉移。
In this study, we achieved the highly specific synergistic radiation by using the design of 2-Deoxy-d-Glucose combined with Graphene Quantum Dot (GQD-2DG) as a passive targeting vector delivery system. treatment. In the experiment, the size of GQD-2DG is about 35nm by TEM. It is judged by FTIR that GQD has 2DG attached and Raman spectroscopy can not change the optical properties of GQD after connecting 2DG. We can use conjugated coke. (Confocal) experiments showed that the grafting of 2DG effectively increased the phagocytosis of osteosarcoma cancer cells. In the animal experiments, the 2DG-GQDs complex was transported to the osteosarcoma cells via the blood delivery vector using the EPR mechanism to significantly increase the nanocarriers in the tumor cells. Accumulation, and simultaneous radiation enhancement with 6MV X-ray irradiation, while inhibiting the distal metastasis of osteosarcoma. In this study, it can be seen that GQD-2DG combined with radiation therapy can effectively reduce tumor size and simultaneously inhibit the distal metastasis of osteosarcoma.
目錄
摘要 Ⅰ
Abstract II
目錄 III
圖目錄 V
表目錄 VII
第一章、緒論 1
第二章、文獻回顧 3
2-1、放射治療 3
2-1-1、輻射與物質效應 3
2-1-2、輻射與生物效應 6
2-1-3、輻射損傷修復 8
2-1-4、放射協同治療 11
2-1-5、輻射增敏 12
2-2、骨肉癌 12
2-3、脫氧葡萄糖 14
2-4、石墨烯簡介 15
2-5、氧化石墨烯介紹 19
2-6、石墨烯量子點介紹 20
2-6-1、石墨烯量子點的性質 20
2-6-2、石墨烯量子點的合成方式 21
第三章、材料方法 25
3-1、實驗藥品 25
3-3、石墨烯量子點的製備 26
3-4、石墨烯量子點包裹脫氧葡萄糖 26
3-5、材料分析 26
3-5-1、穿透式電子式顯微鏡 26
3-5-2、拉曼散射 27
3-5-3、傅立葉轉換紅外光譜儀( Fourier transform infrared spectroscopy,
FTIR ) 27
3-6、體外試驗 27
3-6-1、細胞培養 27
3-6-2、材料毒性測試 28
3-6-3、共軛焦顯微鏡觀察細胞載體吞噬情形 28
3-6-4、克隆形成試驗 29
3-6-5、胞內 ROS 分析 30
3-6-6、γ-H2AX 雙股 DNA 斷裂染色 30
3-6-7、傷口癒合分析 30
3-6-8、Ttanswell 試驗 31
3-6-9 線粒體膜電位( ΔΨm)測定 31
3-7 體內試驗 32
3-7-1、自發性肺轉移模型建立 32
3-7-2、石墨烯量子點動物分布與腫瘤累積 32
3-7-3、異位骨肉瘤動物模型治療 33
3-7-4、原位骨肉瘤自發性肺轉移抑制 33
第四章、實驗結果與討論 35
4-1、材料分析 35
4-1-1、GQD、GQD-2DG 材料結構分析 35
4-1-2、FTIR 材料分析 37
4-1-3、拉曼散射 38
4-2、體外試驗 40
4-2-1、材料毒性測試 40
4-2-2、共軛焦顯微鏡觀察細胞載體吞噬情形 42
4-2-3、克隆形成試驗 44
4-2-4、胞內 ROS 分析 46
4-2-5、γ-H2AX 雙股 DNA 斷裂染色 49
4-2-6、細胞傷口劃分實驗 52
4-2-7、克隆形成試驗 55
4-2-8、線粒體膜電位( ΔΨm)測定 57
4-3 體內試驗 60
4-3-1、原位骨肉瘤動物模型建立 60
4-3-2、石墨烯量子點動物分佈 62
4-3-3、異位骨肉瘤動物模型治療 64
3-3-4、原位骨肉瘤自發性肺轉移抑制 66
第五章、結論 68
參考文獻 69


圖目錄
Fig 1(A)Photoelectric effect (B) Computon effect (C) Pair effect 5
Fig 2 Direct and indirect effects of free radiation 7
Fig 3 HRR and NHEJ repair process 10
Fig 4 Graphene oxide structure 19
Fig 5 Schematic diagram of decomposition of HBC into graphene quantum dots 24
Fig 6 Synthesis scheme and characterization of GQDs and GOQDs of graphite nanoparticle precursors. 24
Fig 7 TEM image of (A)GQD and (C)GQD-2DG (B)GQD size ( nm ) 36
Fig 8 FTIR spectra of GQDs and 2DG、GQD-2DG at 1707 cm-1. 37
Fig 9 Raman spectra of GQDs, GQD-2DG. 39
Fig 10 In vitro cell toxicity assay of different concentrations of GQD and GQD-2DG nanoparticles. Relative viabilities of (A) hFOB1.19、(B) MG63(C) 143B by the Presto Blue assay after incubation with various concentrations of GQD, GQD-2DG, for 24 h. Error bars were based on eight parallel samples. 41
Fig 11 Confocal laser scanning microscope images of (A) hFOB1.19、(B) MG63 (C) 143B cells treated with GQDs and GQD-2DG after incubation for 24 hours concentration of 1 mg/mL. 43
Fig 12 Survival fraction of 143B cells after incubation with GQD (1 mg/mL) or GQD-2DG (1 mg/mL) for 24 hours prior to laddered radiation doses (0, 1, 2, 4, 6, 8 Gy) of 6 MV X-rays. 45
Fig 13 GQD or GQD-2DG enhanced the production of intracellular reactive oxygen species (ROS) in 143B cells. Fluorescent images of CellROX Deep Red representing ROS production. 47
Fig 14 Fluorescent images and intensities were analyzed by Image J software. Quantified values of CellROX Deep Red was analyzed by Image J software. Data are expressed as the mean ± SEM, n = 6, * * * p < 0.001 vs. untreated cells. 48
Fig 15 immunohistochemistry demonstrated γ-H2AX of the MG63 50
Fig 16 immunohistochemistry demonstrated γ-H2AX of the 143B 51
Fig 17 GQD or GQD-2DG-mediated suppressed OS cell migration in vitro.Wound healing assays were performed to examine the migration capacity of (A) MG63 cells treated with Carrier; (B) Quantification of restored surface in A, for 24 、48 h. 53
Fig 18 GQD or GQD-2DG-mediated suppressed OS cell migration in vitro.Wound healing assays were performed to examine the migration capacity of (A) 143B cells treated with Carrier; (B) Quantification of restored surface in A, for 24 、48 h. 54
Fig 19 GQD or GQD-2DG-mediated suppressed OS cell migration in vitro. 56
Fig 20 The mitochondrial transmembrane potential (ΔΨm) was measured by detecting the potential‐dependent accumulation of Mito-kit 59
Fig 21 PET image of (nu/nu) mice (A)Saguttal(B)Coronal(C)Transverse 61
Fig. 22 In vivo imaging and biodistribution of the 63
Fig 23 Tumor volume ratio according to treatment group. Line graphs demonstrating serial change in tumor-volume-ratio (i.e., tumor volume on specific day divided by baseline tumor volume) in each treatment group. GQD-2DG+6Gy group shows slowest growth rate and most
delayed growth spurt among study groups. Significant differences were observed starting in 10day between GQD-2DG+6Gy group and control, 6Gy groups, respectively. 65
Fig 24 GQD or GQD-2DG-mediated antimetastatic activity is shown. (A), This graph shows reduced number of pulmonary nodules in the GQD or GQD-2DG transfected group compared with the control group (n = 3 mice in each group). (B), Quantification of lung surface nodules
in A. 67


表目錄
Table 1 Different ways of making graphene 18
1. Reidy, K., et al., mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells. Photochem Photobiol, 2012. 88(3): p. 721-7.
2. Longhi, A., et al., Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev, 2006. 32(6): p. 423-36.
3. Oi, T., et al., STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma. Int J Oncol, 2016. 49(6): p. 2275-2284.
4. Juzenas, P., et al., Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev, 2008. 60(15): p. 1600-14.
5. Lin, S.-H. and P.-J. Hsieh, Book Review: Kline, RB (2005). Principles and Practice of Structural Equation Modeling . New York: Guilford. 366 pp., $40.50 paperback, ISBN 978-1-57230-690-5. Research on Social Work Practice, 2010. 20(1): p. 126-128.
6. De Certeau, M. and P. Mayol, The Practice of Everyday Life: Living and cooking. Volume 2. Vol. 2. 1998: U of Minnesota Press.
7. Dwarakanath, B. and V. Jain, Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy. Future Oncol, 2009. 5(5): p. 581-5.
8. Mohanti, B.K., et al., Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys, 1996. 35(1): p. 103-11.
9. Pelicano, H., et al., Glycolysis inhibition for anticancer treatment. Oncogene, 2006. 25(34): p. 4633-46.
10. Aft, R.L., F. Zhang, and D. Gius, Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. British journal of cancer, 2002. 87(7): p. 805.
11. Aghaee, F., J. Pirayesh Islamian, and B. Baradaran, Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy. J Breast Cancer, 2012. 15(2): p. 141-7.
12. Bell, S.E., et al., 2-Deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis. Br J Cancer, 1998. 78(11): p. 1464-70.
13. Dwarakanath, B.S., et al., Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. J Cancer Res Ther, 2009. 5 Suppl 1: p. S21-6.
14. Bacon, M., S.J. Bradley, and T. Nann, Graphene quantum dots. Particle & Particle Systems Characterization, 2014. 31(4): p. 415-428.
15. Steel, G.G. and M.J. Peckham, Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. International Journal of Radiation Oncology* Biology* Physics, 1979. 5(1): p. 85-91.
16. Park, S. and R.S. Ruoff, Chemical methods for the production of graphenes. Nature nanotechnology, 2009. 4(4): p. 217.
17. Paredes, J., et al., Graphene oxide dispersions in organic solvents. Langmuir, 2008. 24(19): p. 10560-10564.
18. Stankovich, S., et al., Synthesis of graphene-based nanosheets via chemical reduction of exfoliated graphite oxide. carbon, 2007. 45(7): p. 1558-1565.
19. Wang, G., et al., Facile synthesis and characterization of graphene nanosheets. The Journal of Physical Chemistry C, 2008. 112(22): p. 8192-8195.
20. Boehm, H., M. Eckel, and W. Scholz, Untersuchungen am Graphitoxid V. Über den Bildungsmechanismus des Graphitoxids. Zeitschrift für anorganische und allgemeine Chemie, 1967. 353(5‐6): p. 236-242.
21. Li, L.-s. and X. Yan, Colloidal graphene quantum dots. The Journal of Physical Chemistry Letters, 2010. 1(17): p. 2572-2576.
22. Tang, L., et al., Deep ultraviolet photoluminescence of water-soluble self-passivated graphene quantum dots. ACS nano, 2012. 6(6): p. 5102-5110.
23. Jin, S.H., et al., Tuning the photoluminescence of graphene quantum dots through the charge transfer effect of functional groups. ACS nano, 2013. 7(2): p. 1239-1245.
24. Shen, J., et al., One-pot hydrothermal synthesis of graphene quantum dots surface-passivated by polyethylene glycol and their photoelectric conversion under near-infrared light. New Journal of Chemistry, 2012. 36(1): p. 97-101.
25. Pan, D., et al., Hydrothermal route for cutting graphene sheets into blue‐luminescent graphene quantum dots. Advanced materials, 2010. 22(6): p. 734-738.
26. Zhu, S., et al., Strongly green-photoluminescent graphene quantum dots for bioimaging applications. Chemical communications, 2011. 47(24): p. 6858-6860.
27. Kosynkin, D.V., et al., Longitudinal unzipping of carbon nanotubes to form graphene nanoribbons. Nature, 2009. 458(7240): p. 872.
28. Pan, D., et al., Cutting sp 2 clusters in graphene sheets into colloidal graphene quantum dots with strong green fluorescence. Journal of Materials Chemistry, 2012. 22(8): p. 3314-3318.
29. Liu, R., et al., Bottom-up fabrication of photoluminescent graphene quantum dots with uniform morphology. Journal of the American Chemical Society, 2011. 133(39): p. 15221-15223.
30. Liu, F., et al., Facile synthetic method for pristine graphene quantum dots and graphene oxide quantum dots: origin of blue and green luminescence. Advanced Materials, 2013. 25(27): p. 3657-3662.
31. http://imaging.csmu.edu.tw/ezfiles/48/1048/img/35/20101103.pdf
連結至畢業學校之論文網頁點我開啟連結
註: 此連結為研究生畢業學校所提供,不一定有電子全文可供下載,若連結有誤,請點選上方之〝勘誤回報〞功能,我們會盡快修正,謝謝!
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top